(Q39887208)

15 September 2017

Mast cell degranulation is induced by A549 airway epithelial cell infected with respiratory syncytial virus (English)

1 reference

15 September 2017

0 references

Kazuya Shirato

1

1 reference

15 September 2017

Fumihiro Taguchi

series ordinal

2

1 reference

15 September 2017

language of work or name

English

0 references

publication date

4 February 2009

1 reference

15 September 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

15 September 2017

386

1 reference

15 September 2017

1

1 reference

15 September 2017

88-93

1 reference

Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection. Eosinophils mediate airway hyperresponsiveness, m(2) muscarinic receptor dysfunction, and antiviral effects

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Distinct types of lung disease caused by functional subsets of antiviral T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

A new class of membrane-bound chemokine with a CX3C motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

The role of the mast cell in the pathophysiology of asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Analysis of the interaction between respiratory syncytial virus and lipid-rafts in Hep2 cells during infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Activated mast cells produce interleukin 13.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Establishment of an immature mast cell line from a patient with mast cell leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

The role of virus-specific immunoglobulin E in airway hyperresponsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Respiratory syncytial virus infection in immunocompromised adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Respiratory syncytial virus infection in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

A review of vaccine research and development: human acute respiratory infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Evaluation of quantitative and type-specific real-time RT-PCR assays for detection of respiratory syncytial virus in respiratory specimens from children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Age-induced reprogramming of mast cell degranulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Mast cell activation and leukotriene secretion in wheezing infants. Relation to respiratory syncytial virus and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Respiratory syncytial virus infection in lower respiratory tract and asthma attack in hospitalized children in North Hokkaido, Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

The role of respiratory syncytial virus in acute bronchiolitis in small children in northern Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Tumor necrosis factor, other cytokines and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.011

10.1016/J.VIROL.2009.01.011

7 January 2021

Identifiers

DOI

1 reference

release_fudvyt7prbgvhcnwwnwz2gsi3u

15 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fudvyt7prbgvhcnwwnwz2gsi3u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference